# Synthon Pharmaceuticals, Inc, Durham, NC – FDA Inspections

Source: https://www.keypedia.com/companies/synthon-pharmaceuticals-inc/cf016655-8e6a-4594-a42e-98107c959c23

> Inspection records and compliance data for Synthon Pharmaceuticals, Inc in Durham, North Carolina. 4 FDA inspections on record, last inspected May 18, 2012.

---

## Details

- Name: Synthon Pharmaceuticals, Inc
- FEI Number: 3001238189
- Address Line 1: 9000 Development Dr
- City: Durham
- State: North Carolina
- Zip Code: 27709
- Country Name: United States
- Address: 9000 Development Dr, Durham, North Carolina 27709, United States
- Country: United States

## Related Documents

- [FDA Inspection 782270 - Synthon Pharmaceuticals, Inc - 2012-05-18](https://www.keypedia.com/records/fda_inspections/synthon-pharmaceuticals-inc/e84d1666-82c0-4b8b-8e08-0c3bdf600134) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 18, 2012
- FDA Inspection 658237 - Synthon Pharmaceuticals, Inc - 2010-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2010
- FDA Inspection 658237 - Synthon Pharmaceuticals, Inc - 2010-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2010
- FDA Inspection 659289 - Synthon Pharmaceuticals, Inc - 2010-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2010
- [FDA Inspection 603514 - Synthon Pharmaceuticals, Inc - 2009-04-03](https://www.keypedia.com/records/fda_inspections/synthon-pharmaceuticals-inc/f5283d1b-96aa-443d-a84c-c362f817c0b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 3, 2009

## Related Companies

- [John Green, MD](https://www.keypedia.com/companies/john-green-md/9861d6a7-240d-47d7-bfce-0a98215ebace)
- [North Carolina Clinical Research](https://www.keypedia.com/companies/north-carolina-clinical-research/fe10f7f6-5a16-4f9b-8a0f-2a17b9b2463a)
- [Singaravelu Jagadeesan](https://www.keypedia.com/companies/singaravelu-jagadeesan/dc7c8fdd-b06a-486a-a937-1b96eed0d255)
- [John K. Park, M.D.](https://www.keypedia.com/companies/john-k-park-md/6b435949-28a9-4d80-acee-4861fb334cec)
- [Patrick M. Vollmer, OD, FAAO](https://www.keypedia.com/companies/patrick-m-vollmer-od-faao/76491e39-9275-4228-8e4d-962841e26540)
- [Thomas K. Mundorf, M.D.](https://www.keypedia.com/companies/thomas-k-mundorf-md/d08b96e0-796e-44fb-b3f0-6f8c1fe2272a)
- [Mendolia, Thomas, DO](https://www.keypedia.com/companies/mendolia-thomas-do/f7419794-a8a7-4def-956d-a495b6055f03)
- [New Hope Clinical Research](https://www.keypedia.com/companies/new-hope-clinical-research/b65511c6-4117-4c1c-8083-907bd3250317)
- [Allison K. Ross, M.D.](https://www.keypedia.com/companies/allison-k-ross-md/662ca654-1d47-462c-9ce0-8b0cefe89bef)
- [Eisai Inc](https://www.keypedia.com/companies/eisai-inc/2b3d502f-3252-4131-844e-9b0c6e0e8c6b)